HLA-C and graft versus host disease: GVHD is thought to be mediated through the interaction of donor αβ-TCR with host MHC complexes; therefore, strategies to abrogate GVHD thus far have involved elimination of the αβ-TCR or the use of non-alloreactive cells (such as NK, iPSCs, and virus-specific T-cells discussed above) (52).